Clinical Decision Support Systems Market worth USD 3.7 billion by 2030

The Market Statsville Group (MSG) publishes the new report on the "Clinical Decision Support Systems Market by Product Type (Integrated and Standalone), by Delivery Mode (On-Premise CDSS and Cloud-Based CDSS), by Type (Conventional and Advanced), by Model (Knowledge-Based and Non-Knowledge Based), by Users Interactivity (Active and Passive), by End-Users (Hospitals and Clinics, ASCs, and Others), by Application (Preventive Care, Diagnostics, Follow-Up Management, and Others (Planning and Implementation)), by Region – Global Share and Forecast to 2030". The global clinical decision support systems market size is estimated to grow USD 3.7 billion by 2030 from USD 2.0 billion in 2021, at a CAGR of 6.7% from 2022 to 2030. Clinical decision support systems (CDSSs) can help clinicians assess the risk associated with a chronic disease and manage its risk factors by providing tailored assessments and treatment recommendations based on individual patient data. According to data published by the World Health Organization in 2018, non-communicable or chronic diseases kill 41 million individuals each year, equivalent to 71% of all deaths globally. According to the Centers for Disease Control and Prevention (CDC), the occurrence of chronic diseases can be effectively prevented by eliminating three major risk factors such as poor diet, lack of physical activity, and smoking.

Global Clinical Decision Support Systems Market Segmentation

The overall clinical decision support systems market has been segmented into the product type, delivery mode, type, model, user interactivity, end-users, application, and region.

By Product Type Outlook (Revenue, USD Million, 2017-2030)

• Integrated
• Standalone

By Delivery Mode Outlook (Revenue, USD Million, 2017-2030)

• On-Premise CDSS
• Cloud-Based CDSS

By Type Outlook (Revenue, USD Million, 2017-2030)

• Conventional
• Advanced

By Model Outlook (Sales, USD Million, 2017-2030)

• Knowledge-Based
• Non-Knowledge Based

By Users Interactivity Outlook (Revenue, USD Million, 2017-2030)

• Active
• Passive

By End-Users Outlook (Revenue, USD Million, 2017-2030)

• Hospitals and Clinics
• ASCs
• Others

By Application Outlook (Revenue, USD Million, 2017-2030)

• Preventive Care
• Diagnostics
• Follow-Up Management
• Others
  • Planning
  • Implementation

By Region Outlook (Revenue, USD Million, 2017-2030)

• North America (US, Canada, Mexico)
• South America (Brazil, Argentina, Colombia, Peru, Rest of Latin America)
• Europe (Germany, Italy, France, UK, Spain, Poland, Russia, Slovenia, Slovakia, Hungary, Czech Republic, Belgium, the Netherlands, Norway, Sweden, Denmark, Rest of Europe)
• Asia Pacific (China, Japan, India, South Korea, Indonesia, Malaysia, Thailand, Vietnam, Myanmar, Cambodia, the Philippines, Singapore, Australia & New Zealand, Rest of Asia Pacific)
• The Middle East & Africa (Saudi Arabia, UAE, South Africa, Northern Africa, Rest of MEA)

Advance CDSS, by CDSS type, is estimated to hold the largest market share during the forecast period

The global CDSS market has been segmented based on CDSS type into two broad segments. They are conventional CDSS and advanced CDSS. In 2021, advanced CDSS had the largest market share. Advanced CDSS can perform multiple functions: population health management, health economics management, planning, and protocol validation. The major factor expected to influence the adoption of advanced CDSS positively is a technological advancement in connected healthcare. In terms of adoption, many countries in Europe and North America have high adoption rates. Emerging countries in the Asia-Pacific region and the Middle East are expected to leapfrog technologies during the forecast period 2021-2030. Consequently, by the end of 2030, advanced CDSS is expected to be the standard offering across regions.

Don't miss out on business opportunities in Clinical Decision Support Systems Market. Speak to our research analyst and gain crucial market insights to grow your business.

North America accounts for the largest market share in clinical decision support systems market 2021

Based on the regions, the global clinical decision support systems market has been segmented across North America, Asia-Pacific, Europe, South America, and the Middle East & Africa. In 2020, North America accounted for the highest market share of 55.6% in the global clinical decision support systems market and was anticipated to maintain its dominance throughout the forecast period. Many hospitals and clinics in the North America region are focusing on improving the quality of healthcare by means of patient-specific care. The mode of delivery is mostly on-premise CDSS as cloud-based CDSS are yet to gain end user’s trust due to data security concerns. Ambulatory surgical centers (ASCs) are also expected to register strong growth in terms of CDSS adoption.

Many hospitals and clinics in the North America region are focusing on improving the quality of healthcare using patient-specific care. The mode of delivery is mostly on-premise CDSS as cloud-based CDSS are yet to gain end users’ trust due to data security concerns. Ambulatory surgical centers (ASCs) are also expected to register strong growth in terms of CDSS adoption.

This research report includes a study on the development and marketing strategies, along with a study on the product portfolios and winning strategies of the leading companies operating in the clinical decision support systems market. It also consists of the profiles of leading companies such as Allscripts Healthcare Solutions, Inc., General Electric Company, International Business Machines Corporation, Cerner Corporation, Change Healthcare, McKesson Corporation, RELX Group, Wolters Kluwer N.V., Hearst Corporation, Inferscience, Inc., Medical Information Technology, Inc. Epic Systems Corporation, (MEDITECH), Oncology Analytics, Inc., Persivia Inc., and VisualDx.

Browse complete report: https://www.marketstatsville.com/clinical-decision-support-systems-market

About Market Statsville Group

Market Statsville Group (MSG) is a business research and consulting platform of Statsville Consulting Private Limited, based in Oklahoma, USA. MSG is the leading market research and strategy builder with the depth and breadth of solutions that perfectly suit your every need. MSG provides solutions in a wide range of industry verticals in market sizing, analysis, and intelligent business insights. MSG has experienced research analysts who are proficient at digging deep and providing various customizable data that help you make decisions with clarity, confidence, and impact. Furthermore, Market Statsville Group already benefited more than 1,000 companies each year for their revenue planning. It helped them take their disruptions/innovations early to the market by providing them research ahead of the curve.

MSG has an entire repository of research reports on more than 1,000 niche industries, 3,000 high-growth potentials markets, 5,000 data sets, and more than 12,000 company profiles.

Contact Us:

Market Statsville Group

416, East Standsberry Street, Perkins, Oklahoma 74059, USA

USA: +1-580-205-2707 | +91 702 496 8807

Email: sales@marketstatsville.com

Web: www.marketstatsville.com